Skip to main navigation
Investors
About
Science
Overview
Product Candidates
PRMT5
Overview
PRT543
PRT811
MCL1
Overview
PRT1419
Discovery Engine
Overview
PRT2527 (CDK9)
PRT-SCA2 (SMARCA2)
Publications
Clinical Trials
Overview
PRT543 Trials
PRT811 Trials
PRT1419 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quotes & Charts
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor FAQ's
Contact IR
Email Alerts
News
Careers
Contact
Event Details
We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
H.C. Wainwright BioConnect Virtual Conference
January 10, 2022 at 7:00 AM EST
Click here for Webcast
Print Page
RSS Feeds
Email Alerts
Search
'
About
Science
Overview
Product Candidates
PRMT5
Overview
PRT543
PRT811
MCL1
Overview
PRT1419
Discovery Engine
Overview
PRT2527 (CDK9)
PRT-SCA2 (SMARCA2)
Publications
Clinical Trials
Overview
PRT543 Trials
PRT811 Trials
PRT1419 Trials
Investors
Overview
News & Events
News Releases
Events & Presentations
Financials
SEC Filings
Quarterly Results
Stock Information
Stock Quotes & Charts
Analysts
Governance
Governance Documents
Leadership
Committee Composition
Investor Resources
Investor FAQ's
Contact IR
Email Alerts
News
Careers
Contact